Fei Ye

1.1k total citations
40 papers, 807 citations indexed

About

Fei Ye is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Fei Ye has authored 40 papers receiving a total of 807 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Rheumatology. Recurrent topics in Fei Ye's work include Angiogenesis and VEGF in Cancer (7 papers), Moyamoya disease diagnosis and treatment (5 papers) and Mitochondrial Function and Pathology (3 papers). Fei Ye is often cited by papers focused on Angiogenesis and VEGF in Cancer (7 papers), Moyamoya disease diagnosis and treatment (5 papers) and Mitochondrial Function and Pathology (3 papers). Fei Ye collaborates with scholars based in China, United States and France. Fei Ye's co-authors include Ling Geng, Dennis E. Hallahan, Yu Shyr, Allie Fu, Peng Xie, Peng Zheng, Haiyang Wang, Mei-Xue Dong, Bangmin Yin and Jianjun Chen and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Fei Ye

37 papers receiving 800 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fei Ye China 15 420 111 109 101 89 40 807
Yongsheng Jiang China 17 325 0.8× 88 0.8× 34 0.3× 89 0.9× 135 1.5× 53 828
Valerie Bracchi‐Ricard United States 18 346 0.8× 39 0.4× 50 0.5× 39 0.4× 98 1.1× 27 1.2k
Zhenyu Zhong China 15 402 1.0× 85 0.8× 85 0.8× 88 0.9× 89 1.0× 52 1.5k
Anselm Jünemann Germany 22 414 1.0× 40 0.4× 62 0.6× 29 0.3× 60 0.7× 77 1.6k
Mami Matsumoto Japan 12 376 0.9× 85 0.8× 56 0.5× 31 0.3× 142 1.6× 35 1.2k
Yan Gan China 17 369 0.9× 63 0.6× 35 0.3× 245 2.4× 267 3.0× 49 1.3k
Kelly A. Hogan United States 15 276 0.7× 61 0.5× 51 0.5× 62 0.6× 124 1.4× 23 946
James Keaney Ireland 9 494 1.2× 73 0.7× 48 0.4× 40 0.4× 82 0.9× 17 1.2k
Kyota Fujita Japan 17 494 1.2× 49 0.4× 89 0.8× 115 1.1× 109 1.2× 41 1.2k

Countries citing papers authored by Fei Ye

Since Specialization
Citations

This map shows the geographic impact of Fei Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Ye more than expected).

Fields of papers citing papers by Fei Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Ye. The network helps show where Fei Ye may publish in the future.

Co-authorship network of co-authors of Fei Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Ye. A scholar is included among the top collaborators of Fei Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Ye. Fei Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Man, Xiaoling Li, Jing Lin, et al.. (2025). The Guanylate Cyclase Soluble Subunit Alpha-1 Deficiency Impairs Angiogenesis in Zebrafishes and Mice: In Vivo and In Vitro Studies. Molecular Neurobiology. 62(7). 8248–8260. 2 indexed citations
2.
Dong, Jun, Li Chen, Fei Ye, et al.. (2024). Mic19 depletion impairs endoplasmic reticulum-mitochondrial contacts and mitochondrial lipid metabolism and triggers liver disease. Nature Communications. 15(1). 42 indexed citations
3.
Wang, Yiran, et al.. (2024). The β‐Ketoacyl‐ACP Synthase FabF Catalyzes Carbon‐Carbon Bond Formation in a Bimodal Pattern for Fatty Acid Biosynthesis. Angewandte Chemie International Edition. 63(47). e202407921–e202407921. 4 indexed citations
4.
Chen, Jie, et al.. (2024). Neuregulin 1 as a potential biomarker for disease progression in moyamoya disease: A case-control study in Chinese population. Journal of Stroke and Cerebrovascular Diseases. 33(3). 107581–107581. 1 indexed citations
5.
Ye, Fei, et al.. (2024). Efficacy and safety of intrapleural perfusion with hyperthermic chemotherapy for malignant pleural effusion: a meta-analysis. Journal of Cardiothoracic Surgery. 19(1). 278–278. 2 indexed citations
6.
Ye, Fei, Liang Feng, Yuanyuan Dai, et al.. (2023). RNF213 loss-of-function promotes pathological angiogenesis in moyamoya disease via the Hippo pathway. Brain. 146(11). 4674–4689. 34 indexed citations
7.
Luo, Man, Jing Lin, Fei Ye, et al.. (2023). Loss of Gucy1a3 causes poor post-stroke recovery by reducing angiogenesis via the HIF-1α/VEGFA signaling pathway in mice. Journal of Stroke and Cerebrovascular Diseases. 33(2). 107484–107484. 1 indexed citations
8.
9.
Ye, Fei, et al.. (2021). N6-Methyladenosine RNA modification in cerebrospinal fluid as a novel potential diagnostic biomarker for progressive multiple sclerosis. Journal of Translational Medicine. 19(1). 316–316. 23 indexed citations
10.
Ye, Fei, et al.. (2021). Identification of immune-associated gene signature and immune cell infiltration related to overall survival in progressive multiple sclerosis. Multiple Sclerosis and Related Disorders. 55. 103188–103188. 1 indexed citations
11.
Ye, Fei, Haoyuan Yin, Jiaoxing Li, et al.. (2021). Development and Validation of a Nomogram to Predict the Individual Future Stroke Risk for Adult Patients With Moyamoya Disease: A Multicenter Retrospective Cohort Study in China. Frontiers in Neurology. 12. 669025–669025. 1 indexed citations
12.
Ye, Fei, Jiaoxing Li, Haoyuan Yin, et al.. (2021). Efficacy and Safety of Antiplatelet Agents for Adult Patients With Ischemic Moyamoya Disease. Frontiers in Neurology. 11. 608000–608000. 21 indexed citations
13.
Lin, Jing, Man Luo, Jiaoxing Li, et al.. (2020). Mutations of RNF213 are responsible for sporadic cerebral cavernous malformation and lead to a mulberry-like cluster in zebrafish. Journal of Cerebral Blood Flow & Metabolism. 41(6). 1251–1263. 14 indexed citations
14.
Zhou, Qingzhong, et al.. (2020). miR-27a promotion resulting from silencing of HDAC3 facilitates the recovery of spinal cord injury by inhibiting PAK6 expression in rats. Life Sciences. 260. 118098–118098. 9 indexed citations
15.
Yang, Xun, Guowei Wang, Xue Gong, et al.. (2019). Effects of chronic stress on intestinal amino acid pathways. Physiology & Behavior. 204. 199–209. 11 indexed citations
16.
Ye, Fei, Xiaowei Tang, Jin Li, et al.. (2018). Altered serum levels of vascular endothelial growth factor in first-episode drug-naïve and chronic medicated schizophrenia. Psychiatry Research. 264. 361–365. 9 indexed citations
17.
Ye, Fei, et al.. (2018). Baseline serum vascular endothelial growth factor levels predict treatment response to antipsychotic medication in patients with schizophrenia. European Neuropsychopharmacology. 28(5). 603–609. 14 indexed citations
18.
Pong, Kevin, Cathleen Gonzales, Yi Chen, et al.. (2009). Neuroprotective Profile of Novel Src Kinase Inhibitors in Rodent Models of Cerebral Ischemia. Journal of Pharmacology and Experimental Therapeutics. 331(3). 827–835. 32 indexed citations
19.
20.
Ye, Fei, Marie‐Françoise Bourgeade, Yvon E. Cayre, & Ming Nguy Thang. (2000). A protein kinase C‐independent pathway leading to c‐Jun‐dependent expression of 100‐kDa Ras GTPase‐activating protein in JEG‐3 human choriocarcinoma cells. European Journal of Biochemistry. 267(6). 1589–1597. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yongsheng Jiang Breakdown of academic impact, for papers by Valerie Bracchi‐Ricard Breakdown of academic impact, for papers by Zhenyu Zhong Breakdown of academic impact, for papers by Anselm Jünemann Breakdown of academic impact, for papers by Mami Matsumoto Breakdown of academic impact, for papers by Yan Gan Breakdown of academic impact, for papers by Kelly A. Hogan Breakdown of academic impact, for papers by James Keaney Breakdown of academic impact, for papers by Kyota Fujita
Rankless by CCL
2026